Atria Wealth Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.23M Sell
10,113
-14,245
-58% -$1.61M 0.03% 570
2025
Q1
$2.75M Sell
24,358
-3,345
-12% -$356K 0.03% 521
2024
Q4
$2.7M Buy
27,703
+3,582
+15% +$382K 0.03% 541
2024
Q3
$2.77M Sell
24,121
-1,123
-4% -$127K 0.03% 519
2024
Q2
$2.69M Sell
25,244
-1,108
-4% -$111K 0.03% 531
2024
Q1
$2.59M Buy
26,352
+678
+3% +$69.5K 0.03% 550
2023
Q4
$2.59M Buy
25,674
+3,635
+16% +$351K 0.03% 521
2023
Q3
$2.24M Sell
22,039
-3,323
-13% -$337K 0.03% 521
2023
Q2
$2.56M Buy
25,362
+255
+1% +$25.5K 0.04% 488
2023
Q1
$2.31M Sell
25,107
-1,015
-4% -$88.6K 0.03% 498
2022
Q4
$2.37M Buy
26,122
+2,526
+11% +$213K 0.04% 452
2022
Q3
$1.79M Sell
23,596
-1,764
-7% -$146K 0.03% 524
2022
Q2
$2.14M Buy
25,360
+8,801
+53% +$772K 0.04% 422
2022
Q1
$1.45M Buy
+16,559
New +$1.43M 0.02% 584

Other funds holding NVS